E. V. McCloskey

5.4k total citations · 2 hit papers
19 papers, 3.8k citations indexed

About

E. V. McCloskey is a scholar working on Orthopedics and Sports Medicine, Oncology and Surgery. According to data from OpenAlex, E. V. McCloskey has authored 19 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Orthopedics and Sports Medicine, 10 papers in Oncology and 4 papers in Surgery. Recurrent topics in E. V. McCloskey's work include Bone health and treatments (10 papers), Bone health and osteoporosis research (10 papers) and Bone and Joint Diseases (6 papers). E. V. McCloskey is often cited by papers focused on Bone health and treatments (10 papers), Bone health and osteoporosis research (10 papers) and Bone and Joint Diseases (6 papers). E. V. McCloskey collaborates with scholars based in United Kingdom, Sweden and Australia. E. V. McCloskey's co-authors include J. A. Kanis, B. Jönsson, J. Compston, Cyrus Cooper, J Stenmark, M Ivergård, A Svedbom, E Hernlund, John А. Kanis and Anders Odén and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

E. V. McCloskey

18 papers receiving 3.7k citations

Hit Papers

Osteoporosis in the European Union: medical management, e... 2013 2026 2017 2021 2013 2013 500 1000 1.5k

Peers

E. V. McCloskey
Sanford Baim United States
Lee J. Melton United States
G. Campion United Kingdom
E. V. McCloskey
Citations per year, relative to E. V. McCloskey E. V. McCloskey (= 1×) peers Wojciech P. Olszynski

Countries citing papers authored by E. V. McCloskey

Since Specialization
Citations

This map shows the geographic impact of E. V. McCloskey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. V. McCloskey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. V. McCloskey more than expected).

Fields of papers citing papers by E. V. McCloskey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. V. McCloskey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. V. McCloskey. The network helps show where E. V. McCloskey may publish in the future.

Co-authorship network of co-authors of E. V. McCloskey

This figure shows the co-authorship network connecting the top 25 collaborators of E. V. McCloskey. A scholar is included among the top collaborators of E. V. McCloskey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. V. McCloskey. E. V. McCloskey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Johansson, H, Olivier Bruyère, Mattias Lorentzon, et al.. (2025). A surrogate FRAX model for Mongolia. Archives of Osteoporosis. 20(1). 27–27.
2.
Ye, Carrie, William D. Leslie, Lin Yan, et al.. (2024). Fracture Risk Prediction Using the Fracture Risk Assessment Tool in Individuals With Cancer. JAMA Oncology. 10(11). 1554–1554. 2 indexed citations
3.
Duerksen, Donald R., Lisa M. Lix, Helena Johansson, et al.. (2020). Fracture risk assessment in celiac disease: a registry-based cohort study. Osteoporosis International. 32(1). 93–99. 12 indexed citations
4.
Zerbini, Cristiano A. F., et al.. (2015). Incidence of hip fracture in Brazil and the development of a FRAX model. Archives of Osteoporosis. 10(1). 224–224. 69 indexed citations
5.
Svedbom, A, E Hernlund, M Ivergård, et al.. (2013). Osteoporosis in the European Union: a compendium of country-specific reports. Archives of Osteoporosis. 8(1-2). 137–137. 547 indexed citations breakdown →
6.
Hernlund, E, A Svedbom, M Ivergård, et al.. (2013). Osteoporosis in the European Union: medical management, epidemiology and economic burden. Archives of Osteoporosis. 8(1-2). 136–136. 1966 indexed citations breakdown →
7.
Johansson, H, Alkım Öden Akman, E. V. McCloskey, & John А. Kanis. (2013). Mild morphometric vertebral fractures predict vertebral fractures but not non-vertebral fractures. Osteoporosis International. 25(1). 235–241. 56 indexed citations
8.
Kanis, J. A., Helena Johansson, Anders Odén, & E. V. McCloskey. (2011). Guidance for the adjustment of FRAX according to the dose of glucocorticoids. Osteoporosis International. 22(3). 809–816. 215 indexed citations
9.
Kanis, J. A., Håkan Johansson, Anders Odén, & E. V. McCloskey. (2011). A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX®. Osteoporosis International. 22(8). 2347–2355. 74 indexed citations
10.
McCloskey, E. V., Janet Dunn, John А. Kanis, Ian C. M. MacLennan, & Mark T. Drayson. (2001). Long‐term follow‐up of a prospective, double‐blind, placebo‐controlled randomized trial of clodronate in multiple myeloma. British Journal of Haematology. 113(4). 1035–1043. 136 indexed citations
11.
McCloskey, E. V., Julian F. Guest, & J. A. Kanis. (2001). The Clinical and Cost Considerations of Bisphosphonates in Preventing Bone Complications in Patients with Metastatic Breast Cancer or Multiple Myeloma. Drugs. 61(9). 1253–1274. 29 indexed citations
12.
Kanis, John A. & E. V. McCloskey. (2000). Bisphosphonates in multiple myeloma. Cancer. 88(S12). 3022–3032. 43 indexed citations
13.
O’Neill, Terence W, E. V. McCloskey, John А. Kanis, et al.. (1999). The distribution, determinants, and clinical correlates of vertebral osteophytosis: a population based survey.. PubMed. 26(4). 842–8. 152 indexed citations
14.
Masud, Tahir, I Mootoosamy, E. V. McCloskey, et al.. (1996). Assessment of osteopenia from spine radiographs using two different methods: the Chingford study. British Journal of Radiology. 69(821). 451–456. 15 indexed citations
15.
O’Rourke, N., E. V. McCloskey, Frank Houghton, Harold T. Huss, & John А. Kanis. (1995). Double-blind, placebo-controlled, dose-response trial of oral clodronate in patients with bone metastases.. Journal of Clinical Oncology. 13(4). 929–934. 49 indexed citations
16.
Doyle, David, et al.. (1994). Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis.. Annals of the Rheumatic Diseases. 53(2). 117–121. 157 indexed citations
17.
O’Rourke, N., et al.. (1993). Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronate. British Journal of Cancer. 67(3). 560–563. 64 indexed citations
18.
Taube, T., M.N.C. Benéton, E. V. McCloskey, et al.. (1992). Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption. European Journal Of Haematology. 49(4). 192–198. 154 indexed citations
19.
Hamdy, Neveen A. T., E. V. McCloskey, C. Brown, & John А. Kanis. (1990). Effects of Clodronate in Severe Hyperparathyroid Bone Disease in Chronic Renal Failure. ˜The œNephron journals/Nephron journals. 56(1). 6–12. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026